Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shogo Narimatsu"'
Autor:
Aiko Hasegawa, Shoji Saito, Shogo Narimatsu, Shigeru Nakano, Mika Nagai, Hideki Ohnota, Yoichi Inada, Hirokazu Morokawa, Ikumi Nakashima, Daisuke Morita, Yuichiro Ide, Kazuyuki Matsuda, Haruko Tashiro, Shigeki Yagyu, Miyuki Tanaka, Yozo Nakazawa
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 5, Pp n/a-n/a (2021)
Abstract Objectives As the prognosis of relapsed/refractory (R/R) acute myeloid leukaemia (AML) remains poor, novel treatment strategies are urgently needed. Clinical trials have shown that chimeric antigen receptor (CAR)‐T cells for AML are more c
Externí odkaz:
https://doaj.org/article/1425b53972624649b7548613523d6ce8
Autor:
Hiroshi Inakura, Yohei Mukai, Shogo Narimatsu, Yasuo Yoshioka, Aya Tanabe, Shinsaku Nakagawa, Naoki Okada, Xinglei Yao, Shin-ichi Tsunoda, Tomohiro Morishige, Yasuo Tsutsumi, Youko Monobe, Takayoshi Imazawa
Publikováno v:
Archives of Toxicology. 86:1297-1307
It has gradually become evident that nanomaterials, which are widely used in cosmetics, foods, and medicinal products, could induce substantial inflammation. However, the roles played by the physical characteristics of nanomaterials in inflammatory r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49cc6edf79c71518a61e97966f8976b9
https://doi.org/10.1007/s00204-012-0823-5
https://doi.org/10.1007/s00204-012-0823-5
Autor:
Shinsaku Nakagawa, Naoki Okada, Tomohiro Morishige, Yohei Mukai, Shogo Narimatsu, Yasuo Yoshioka, Shin-ichi Tsunoda, Xinglei Yao, Yasuo Tsutsumi, Michael I Nishimura
Publikováno v:
Biochemical and Biophysical Research Communications. 415:558-562
T-cell receptors (TCR) recognize complexes between human leukocyte antigens (HLA) and peptides derived from intracellular proteins. Their therapeutic use for antigen targeting, however, has been hindered by the very low binding affinity of TCRs, typi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df42b2c97d400d1dc28f16b4dd783d7
https://doi.org/10.1016/j.bbrc.2011.10.092
https://doi.org/10.1016/j.bbrc.2011.10.092
Autor:
Yohei Mukai, Hikaru Watanabe, Tomohiro Morishige, Shogo Narimatsu, Yasuo Yoshioka, Xinglei Yao, Shin-ichi Tsunoda, Shinsaku Nakagawa, Aya Tanabe, Takashi Masano, Yasuo Tsutsumi, Naoki Okada
Publikováno v:
Cytokine. 56:489-493
The cytokine lymphotoxin-α (LTα) is a promising anticancer agent; however, its instability currently limits its therapeutic potential. Modification of proteins with polyethylene glycol (PEGylation) can improve their in vivo stability, but PEGylatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5116eb45f78f675c146ce341748bc77e
https://doi.org/10.1016/j.cyto.2011.08.021
https://doi.org/10.1016/j.cyto.2011.08.021
Autor:
Shogo Yamamoto, Miho Miura, Hiroyuki Katayama, Takashi Furukawa, Shogo Narimatsu, Yoshihiro Suzuki, Akira Iwakiri
Publikováno v:
Journal of Bioscience and Bioengineering. 112:369-372
The monitoring of NVs in municipal wastewater by both real-time RT-LAMP and real-time RT-PCR, and the comparison of these two methods with respect to NV detection were carried out. The change in NVs detected by real-time RT-LAMP agreed well with that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b63c7b6370b9de23047037543054ee8a
https://doi.org/10.1016/j.jbiosc.2011.06.012
https://doi.org/10.1016/j.jbiosc.2011.06.012
Autor:
Tomohiro Morishige, Yusuke Eto, Xinglei Yao, Hiroyuki Mizuguchi, Yohei Mukai, Naoki Okada, Shogo Narimatsu, Shinsaku Nakagawa, Yasuo Yoshioka
Publikováno v:
Biological and Pharmaceutical Bulletin. 33:1073-1076
Cancer gene therapy with adenovirus vectors (Adv) is limited to local administration because systemic administration of Adv produces a weak therapeutic effect and severe side effects. Previously, we generated a dual cancer-specific Adv system by usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9edc56ef740b1dc2f988f3e495bdede6
https://doi.org/10.1248/bpb.33.1073
https://doi.org/10.1248/bpb.33.1073
Autor:
Yasuo Yoshioka, Yohei Mukai, Shogo Narimatsu, Tomohiro Morishige, Shinji Ikemizu, Shin-ichi Tsunoda, Naoki Okada, Shinsaku Nakagawa, Yasuo Tsutsumi
Publikováno v:
Cytokine. 61(2)
The cytokine lymphotoxin-α (LTα) is a promising candidate for use in cancer therapy. However, the instability of LTαin vivo and the insufficient levels of tumor necrosis factor receptor 1 (TNFR1)-mediated bioactivity of LTα limit its therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a34f2a23adeebcc07d7fd9038389027
https://pubmed.ncbi.nlm.nih.gov/23246116
https://pubmed.ncbi.nlm.nih.gov/23246116
Autor:
Yasuaki Kawai, Hiroyuki Mizuguchi, Naoki Okada, Yohei Mukai, Jian-Qing Gao, Yasuo Yoshioka, Shinsaku Nakagawa, Shogo Narimatsu, Yusuke Eto, Tomohiro Morishige, Xinglei Yao
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 19(9)
Previously, we generated a cancer-specific gene therapy system using adenovirus vectors (Adv) conjugated to polyethylene glycol (Adv-PEG). Here, we developed a novel Adv that targets both tumor tissues and tumor vasculatures after systemic administra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5889cfa5d35b94b14759d3280643c8bd
https://pubmed.ncbi.nlm.nih.gov/21673661
https://pubmed.ncbi.nlm.nih.gov/21673661
Autor:
Xinglei Yao, Hiroshi Kiwada, Shinsaku Nakagawa, Yohei Mukai, Shogo Narimatsu, Tomohiro Morishige, Yasuo Yoshioka, Hiroyuki Mizuguchi, Yusuke Eto, Naoki Okada, Tatsuhiro Ishida
Publikováno v:
Biologicalpharmaceutical bulletin. 33(9)
Application of adenovirus vectors (Adv) in metastatic cancer treatment is limited. We previously demonstrated that covalent conjugation of polyethleneglycol (PEG) to Adv enhances therapeutic effects and decreases toxic side-effects after systemic adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68edafebb5828c6e1e0ddc9b4b029fd8
https://pubmed.ncbi.nlm.nih.gov/20823571
https://pubmed.ncbi.nlm.nih.gov/20823571
Autor:
Xinglei Yao, Takayoshi Imazawa, Shinsaku Nakagawa, Hiroshi Inakura, Yasuo Yoshioka, Yasuo Tsutsumi, Yohei Mukai, Shin-ichi Tsunoda, Shogo Narimatsu, Aya Tanabe, Naoki Okada, Youko Monobe, Tomohiro Morishige
Publikováno v:
Biomaterials. 31(26)
Although amorphous silica particles (SPs) are widely used in cosmetics, foods and medicinal products, it has gradually become evident that SPs can induce substantial inflammation accompanied by interleukin-1beta (IL-1beta) production. Here, to develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec90605bebc50ee95b45a45c8c268d3a
https://pubmed.ncbi.nlm.nih.gov/20561679
https://pubmed.ncbi.nlm.nih.gov/20561679